Independent Directors Meeting
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Shukra Pharmaceuticals Ltd held its separate meeting of Independent Directors for FY 2025-26 on Monday, 16th March 2026, from 1:00 PM to 1:30 PM at the company's registered office in Ahmedabad. The meeting was held as per SEBI (LODR) Regulation 25(3) and Schedule IV of the Companies Act, 2013. During the meeting, the Independent Directors reviewed the performance of non-independent directors and the board as a whole, assessed the performance of the chairperson, and evaluated the quality, quantity, and timeliness of information flow between management and the board. The outcome was submitted to BSE under Regulation 30 of the SEBI (LODR) Regulations, 2015.
This is a routine corporate governance compliance filing with no material impact on the company's financials, operations, or stock price. It simply confirms that the company has met its regulatory requirement of conducting an annual independent directors' review.